Concepedia

David Harden

DH

Statistics

Publications

24

Citations

1.1K

H-Index

18

Active since

1992

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

University of Pittsburgh

Bristol-Myers Squibb (Canada)

Institute for Research in Immunology and Cancer

David Harden is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and molecular pharmacology.

Publications per year

1992–2024

24

Publications

24

A Thallium-Sensitive, Fluorescence-Based Assay for Detecting and Characterizing Potassium Channel Modulators in Mammalian Cells

C. David Weaver, David Harden, Steven I. Dworetzky et al. · SLAS DISCOVERY · 2004 · 170 citations · Full text

, , +17

Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding

Pancras C. Wong, Dietmar Seiffert, J. Eileen Bird et al. · Science Translational Medicine · 2017 · 149 citations

, , +14

Effects of amygdala lesions on reflex facilitation and conditioned response acquisition during nictitating membrane response conditioning in rabbit.

Donald J. Weisz, David Harden, Zixiu Xiang · Behavioral Neuroscience · 1992 · 99 citations

, , +12

Effects of amygdala lesions on reflex facilitation and conditioned response acquisition during nictitating membrane response conditioning in rabbit.

Donald J. Weisz, David Harden, Zixiu Xiang · Behavioral Neuroscience · 1992 · 87 citations

, , +12

Fluorine Substitution Can Block CYP3A4 Metabolism-Dependent Inhibition:  Identification of (<i>S</i>)<i>-N</i>-[1-(4-Fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an Orally Bioavailable KCNQ2 Opener Devoid of CYP3A4 Metabolism-Dependent Inhibition

Yong‐Jin Wu, Carl D. Davis, Steven I. Dworetzky et al. · Journal of Medicinal Chemistry · 2003 · 58 citations · Full text

, , +11

1–5 of 24